← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2003Last known activity
Jan 1, 2016
Acquired by McKesson on Dec 30, 2010
Timeline
1990s
- Jun 1, 1992
US Oncology— Founded
2010s
- Dec 30, 2010
McKesson— Acquired By
Drugs by trial phase (44 distinct, 33 trials)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Fatigue
- Hypersensitivity
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lung Neoplasms
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Mucositis
- Neoplasm Metastasis
- Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Rectal Neoplasms
- Stomatitis
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT02645175CollaboratorPhase 2Jan 1, 2016
- NCT02425683Lead sponsorPhase 2Mar 1, 2015
- NCT02425683Overall official - principal investigatorPhase 2Mar 1, 2015
- NCT02187991Lead sponsorPhase 2Feb 1, 2015
- NCT02187991Overall official - principal investigatorPhase 2Feb 1, 2015
- NCT02229149Overall official - principal investigatorPhase 2Dec 1, 2014
- NCT02229149Lead sponsorPhase 2Dec 1, 2014
- NCT02229136Lead sponsorPhase 2Sep 4, 2014
- NCT02229136Overall official - principal investigatorPhase 2Sep 4, 2014
- NCT02000882Overall official - principal investigatorPhase 2May 29, 2014
- NCT02000882Lead sponsorPhase 2May 29, 2014
- NCT02032277CollaboratorPhase 3Apr 2, 2014
- NCT01934634Lead sponsorPhase 1Mar 1, 2014
- NCT01934634Overall official - principal investigatorPhase 1Mar 1, 2014
- NCT01905592CollaboratorPhase 3Oct 1, 2013
Details
- Founded
- The Woodlands, TX, US Jun 1, 1992
- Last known activity
- Jan 1, 2016
Notes
CRO